The next frontier for multibillion-dollar drug therapies is a silent disease many people don't know they have. Dozens of pharmaceutical companies including Gilead Sciences Inc., Allergan PLC and ...
New data confirming that Gilead Sciences Inc.’s Hepcludex (bulevirtide) effectively cures hepatitis delta virus (hepatitis D), one of the most severe viral infections of the liver, and favorable phase ...
Resmetirom is the first FDA-approved drug for NASH with liver fibrosis, offering a new treatment option alongside lifestyle changes. Clinical trials demonstrated significant NASH resolution and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback